Peter Goldschmidt

Peter Goldschmidt is the Chief Executive Officer of STADA Arzneimittel AG, a position he has held since September 1, 2018.13 He is an experienced pharmaceutical industry executive with over 30 years in the field.1

Goldschmidt's career highlights include:

1. CEO of STADA Group (2018-present)3
2. President of Sandoz US and Head of North America (2013-2018)3
3. Head of Sandoz Central and Eastern Europe (2009-2013)3
4. Various leadership roles at Novartis in Germany, Sweden, and Asia (1990-2009)3

Under Goldschmidt's leadership, STADA has implemented a growth mindset culture based on the purpose of "Caring for People's Health as a Trusted Partner".1 He has led the company to consistently deliver above-market sales and profit growth, with STADA's sales doubling since he took over.2

Goldschmidt is known for his focus on entrepreneurship, agility, and fostering a strong company culture.2 He has made "growth mindset" one of STADA's five strategic pillars and emphasizes the importance of hiring people who are positive and see opportunities others don't.2

His educational background includes studies at the University of Münster, as well as executive education at Stanford University Graduate School of Business, London Business School, and Harvard Business School.3